Recursion Pharmaceuticals Inc

22 sept. 2026, 19:50 UTC

Recursion Pharmaceuticals' stock is advancing after extending a data license agreement with Tempus AI, involving $42 million in committed payments over three years.

21 sept. 2026, 23:30 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, contrasting with recent gains, though it remains above its 20-day moving average.

19 sept. 2026, 00:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, moving lower since Friday's close, with notable momentum shifts observed during the session.

18 sept. 2026, 23:41 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, moving lower since Friday's close, despite remaining significantly above its 20-day moving average.

17 sept. 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is trading modestly lower in after-market hours, moving in sympathy with Schrodinger Inc amid mixed economic indicators.

16 sept. 2026, 22:51 UTC

Recursion Pharmaceuticals Inc is moving higher in after-market trading, reflecting broader market gains following a sharp rise in U.S. retail sales in August.

15 sept. 2026, 23:02 UTC

Recursion Pharmaceuticals Inc. shares are higher in after-market trading, following the broader market's upward trend despite no specific company news.

14 sept. 2026, 20:08 UTC

Recursion Pharmaceuticals is gaining today, benefiting from Schrödinger's collaboration agreement with Tectora Therapeutics. Earlier, shares pulled back but have since recovered.

11 sept. 2026, 19:46 UTC

Recursion Pharmaceuticals Inc shares are higher during Friday's session, despite a slight pullback from earlier highs. No specific news was identified for the move.

10 sept. 2026, 23:16 UTC

No specific news was identified for Recursion Pharmaceuticals Inc. during after-market hours. The stock remained roughly flat since Thursday's close.

9 sept. 2026, 23:06 UTC

Recursion Pharmaceuticals Inc shares are higher in after-market trading, following a notable peak earlier in the session with no specific news identified.

8 sept. 2026, 22:51 UTC

Recursion Pharmaceuticals Inc shares are higher in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

4 sept. 2026, 20:08 UTC

Recursion Pharmaceuticals shares are higher today, continuing an upward trend since Thursday's close, amid broader market dynamics following a strong jobs report.

3 sept. 2026, 23:21 UTC

Recursion Pharmaceuticals Inc. shares declined in after-market trading, following a peak shortly after the market closed and amid broader market weakness.

2 sept. 2026, 23:06 UTC

Recursion Pharmaceuticals Inc shares are lower in after-market trading. The decline comes amid a weaker ADP private payrolls report impacting overall market sentiment.

1 sept. 2026, 20:09 UTC

Recursion Pharmaceuticals Inc. shares are lower, following broader market declines amid rising oil prices and increasing U.S. Treasury yields. No specific company news was identified.

31 août 2026, 23:06 UTC

Recursion Pharmaceuticals Inc shares are lower in after-market hours. Market sentiment reflects recent comments from Federal Reserve Chair Kevin Warsh on inflation and interest rates.

28 août 2026, 23:51 UTC

Recursion Pharmaceuticals Inc shares are higher in after-market hours, following three consecutive lower finishes. No specific news was identified to explain the movement.

27 août 2026, 23:02 UTC

Recursion Pharmaceuticals Inc shares are trading higher in after-market hours. No specific news was identified to explain the price movement.

26 août 2026, 20:08 UTC

Recursion Pharmaceuticals is declining amid a broader downturn in the Biotechnology sub-sector, with the ARK Genomic Revolution ETF also experiencing losses.

25 août 2026, 23:01 UTC

Recursion Pharmaceuticals Inc shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

24 août 2026, 20:02 UTC

Recursion Pharmaceuticals Inc shares are lower amid broader market declines, with analysts rating the stock as a "Hold" and price targets between $5.30 and $10.00.

21 août 2026, 20:06 UTC

Recursion Pharmaceuticals Inc shares are higher during Friday's session, reflecting strong momentum since Thursday's close amid favorable conditions in the biotechnology sector.

20 août 2026, 20:06 UTC

Recursion Pharmaceuticals Inc shares are lower today, reflecting broader market trends. The stock's decline aligns with weakness in correlated assets.

19 août 2026, 23:01 UTC

Recursion Pharmaceuticals Inc shares are lower in after-market hours after a volatile session, declining from the upper end of its one-month range.

18 août 2026, 20:04 UTC

Recursion Pharmaceuticals Inc shares are lower today amid broader market pressures on small-cap stocks and rising U.S. Treasury yields affecting sentiment.

17 août 2026, 19:36 UTC

Recursion Pharmaceuticals shares decline as Morgan Stanley cuts the price target to $5.30 from $5.50, reflecting ongoing valuation concerns.

12 août 2026, 19:56 UTC

Recursion Pharmaceuticals Inc is trading lower, reflecting a decline from Tuesday's close. The stock remains above its 20-day moving average despite today's pullback.

11 août 2026, 19:36 UTC

Recursion Pharmaceuticals Inc. is higher today amid positive market sentiment and over $500 million in milestone payments from partnerships with Genentech/Roche and Sanofi.

10 août 2026, 20:06 UTC

Recursion Pharmaceuticals Inc is higher Monday amid ongoing interest, despite social media concerns about its clinical pipeline and integration challenges with Exscientia.